Disease | crohn disease |
Phenotype | C0021390|inflammatory bowel disease |
Sentences | 23 |
PubMedID- 21272808 | inflammatory bowel disease (ibd) consists of two subtypes, crohn's disease (cd) and ulcerative colitis (uc), and represents a common form of chronic intestinal inflammation. |
PubMedID- 20517857 | Background: arterial and venous thrombosis are well recognized systemic complications of inflammatory bowel disease predominantly in patients with crohn's colitis and in those with ulcerative colitis (uc). |
PubMedID- 19582502 | Background: to compare magnetic resonance enterography (mre) and computed tomography enterography (cte) in detecting inflammatory bowel disease activity (ibd) in patients with crohn's disease (cd). |
PubMedID- 24348149 | inflammatory bowel disease mainly consisting of ulcerative colitis and crohn's disease has been rising gradually during the last two decades in china. |
PubMedID- 22908971 | Objective: this study was aimed to investigate the possible association of crohn's disease (cd) with inflammatory bowel disease gene 5 (ibd5) igr2198a_1 (rs11739135), igr2096a_1 (rs12521868) and interleukin-23 receptor (il23r) genetic variant (rs1004819) in the malaysian population. |
PubMedID- 24082485 | The most common indication for mre is inflammatory bowel disease with crohn disease much more common than ulcerative colitis. |
PubMedID- 21370319 | Background: inflammatory bowel diseases (ibds) are comprised of two major disorders: crohn's disease (cd) and ulcerative colitis (uc). |
PubMedID- 25032716 | inflammatory bowel diseases are a group of gastrointestinal diseases including crohn's disease and ulcerative colitis, that is, syndromes characterized by changes in mucosal immunity and gastrointestinal physiology, which could negatively influence the vascular endothelial function and structure. |
PubMedID- 21355357 | Glucocorticoids, a type of steroid hormone, are widely used in the treatment of inflammatory bowel disease (ibd) in patients with crohn's disease or ulcerative colitis. |
PubMedID- 25812483 | Background: inflammatory bowel diseases (ibd), comprised of ulcerative colitis and crohn's disease, are chronic disorders characterized by worsening of symptoms followed by symptom-free periods. |
PubMedID- 20359151 | Nutrition has an important role in the management of inflammatory bowel disease (ibd), especially in patients with crohn's disease (cd). |
PubMedID- 21180606 | Although biologic agents directed against tumor necrosis factor alpha (tnfalpha) continue to be an effective therapeutic strategy for patients with inflammatory bowel disease (ibd), approximately 30% of patients with crohn's disease (cd) who are refractory to standard treatment do not respond to induction therapy with tnfalpha inhibitors and, of those who initially respond, 50% or more cease to respond within a year. |
PubMedID- 25427048 | inflammatory bowel diseases are a group of gastrointestinal diseases including crohn's disease and ulcerative colitis, that is, syndromes characterized by changes in mucosal immunity and gastrointestinal physiology, which could negatively influence the vascular endothelial function and structure. |
PubMedID- 24127239 | inflammatory bowel disease (ibd), consisting of both crohn's disease (cd) and ulcerative colitis (uc), are chronic inflammatory conditions of the intestinal tract. |
PubMedID- 25553076 | inflammatory bowel disease (ibd), comprised of ulcerative colitis and crohn's disease, is believed to develop as a result of a deregulated inflammatory response to environmental factors in genetically susceptible individuals. |
PubMedID- 22346247 | inflammatory bowel disease is a group of diseases that includes crohn's disease (cd) and ulcerative colitis. |
PubMedID- 23251399 | For the cancer site specific analyses, models were further adjusted for cholecystectomy, inflammatory bowel disease (consisting of crohn's disease and ulcerative colitis), and a history of polyps for colorectal cancer; oophorectomy, use of hormone replacement therapy, and prior use of oral contraceptives for breast cancer; and benign prostatic hyperplasia, prostatitis, and use of 5-alpha reductase inhibitors (finasteride or dutasteride) for prostate cancer. |
PubMedID- 25348881 | Anti-tnf-alpha treatment for post-anastomotic ulcers and inflammatory bowel disease with crohn's-like pathologic changes following intestinal surgery in pediatric patients. |
PubMedID- 25213590 | Although an elevated calprotectin level indicates inflammation in the bowel, it cannot identify the cause.1 faecal calprotectin testing is mainly used in distinguishing between 'functional' disorders such as irritable bowel syndrome and 'organic' disorders, such as inflammatory bowel disease, a group of conditions including crohn's disease and ulcerative colitis that require referral to specialist services. |
PubMedID- 25409212 | Material and methods: one hundred thirty eight consecutive inflammatory bowel disease outpatients (55.8% with crohn's disease and 44.2% with ulcerative colitis) filled in an anonymous questionnaire, which included information about demography, duration of the disease, specific therapy for inflammatory bowel disease, and data possibly related to extent of non-adherence to treatment. |
PubMedID- 20586858 | With respect to inflammatory bowel diseases, 71.4% of the patients with crohn's disease and all patients with ulcerative colitis were assigned to group a or b. |
PubMedID- 19437119 | inflammatory bowel disease (ibd) consists of ulcerative colitis and crohn's disease, both of which are associated with increased colorectal cancer risk. |
PubMedID- 26228368 | Patients and methods: the present study included 528 inflammatory bowel disease patients, 224 with crohn's disease and 304 with ulcerative colitis, and 339 healthy controls. |
Page: 1